Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20780018 | 0.97 | MEN1 (0.34) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL26941819 | 0.94 | MEN1 (0.41) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL26941817 | 0.89 | ACACB (0.31) | MEN1MAPK1KMT2A | |
| SCHEMBL10348107 | 0.89 | MAPK1 (0.36) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL21577523 | 0.88 | MEN1 (0.36) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL25056666 | 0.88 | MEN1 (0.36) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL29305993 | 0.87 | FFAR1 (0.30) | — | |
| SCHEMBL26941851 | 0.87 | MEN1 (0.36) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL23051712 | 0.87 | ESR1 (0.30) | CYP2C9ESR2 | |
| SCHEMBL29165244 | 0.86 | MEN1 (0.33) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20230400721-A1 | METHOD FOR PRODUCING LIQUID CRYSTAL MATERIAL, METHOD FOR EVALUATING LIQUID CRYSTAL MATERIAL, MEASUREMENT APPARATUS THEREFOR, AND LIQUID CRYSTAL MATERIAL | DIC CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| US-20230400721-A1 | METHOD FOR PRODUCING LIQUID CRYSTAL MATERIAL, METHOD FOR EVALUATING LIQUID CRYSTAL MATERIAL, MEASUREMENT APPARATUS THEREFOR, AND LIQUID CRYSTAL MATERIAL | DIC CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| US-20230313044-A1 | COMPOUND, COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND DEVICE | DIC CORPORATION (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230313044-A1 | COMPOUND, COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND DEVICE | DIC CORPORATION (JP) | 2023-10-05 | — | — | US | disclosed |
| US-10224620-B2 | Antenna having radio frequency liquid crystal (RFLC) mixtures with high RF tuning, broad thermal operating ranges, and low viscosity | KYMETA CORPORATION (US) | 2019-03-05 | — | — | US | disclosed |
| EP-2799516-B1 | LIQUID CRYSTAL MATERIAL OF SMECTIC PHASE IN HIGH SCATTERING STATE AND DISPLAY DEVICE THEREOF | HALATION PHOTONICS CORP (CN) | 2019-02-20 | — | — | EP | disclosed |
| US-9175220-B2 | High scattering smectic liquid crystal material and display device using the same | HALATION PHOTONICS CORPORATION (CN) | 2015-11-03 | — | — | US | disclosed |
| US-9175220-B2 | High scattering smectic liquid crystal material and display device using the same | HALATION PHOTONICS CORPORATION (CN) | 2015-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230313044-A1 | COMPOUND, COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND DEVICE | NLK, TTI2, LBR | MEN1 1839/4885MAPK1 562/4885KMT2A 4036/4885 |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | TTI2, CCT4, CCT2 | MEN1 2827/4885MAPK1 1226/4885KMT2A 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.